FIGURE 3.
The cumulative incidence of mortality (A) and cirrhotic decompensation (B) between metformin users and nonusers in T2DM with compensated liver cirrhosis, by the Fine and Gray's sub‐distribution hazard method
The cumulative incidence of mortality (A) and cirrhotic decompensation (B) between metformin users and nonusers in T2DM with compensated liver cirrhosis, by the Fine and Gray's sub‐distribution hazard method